These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 24244714)
1. Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma. Cheng XB; Sato N; Kohi S; Yamaguchi K PLoS One; 2013; 8(11):e80765. PubMed ID: 24244714 [TBL] [Abstract][Full Text] [Related]
2. Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance? Gebauer F; Kemper M; Sauter G; Prehm P; Schumacher U PLoS One; 2017; 12(6):e0178703. PubMed ID: 28582436 [TBL] [Abstract][Full Text] [Related]
3. Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer. Tahkola K; Ahtiainen M; Mecklin JP; Kellokumpu I; Laukkarinen J; Tammi M; Tammi R; Väyrynen JP; Böhm J Sci Rep; 2021 Jun; 11(1):12216. PubMed ID: 34108626 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma. Lu J; Zhou L; Yang G; Liang ZY; Zhou WX; You L; Yuan D; Li BQ; Guo JC; Zhao YP Hum Pathol; 2019 Apr; 86():143-154. PubMed ID: 30537492 [TBL] [Abstract][Full Text] [Related]
5. Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight. Sato N; Kohi S; Hirata K; Goggins M Cancer Sci; 2016 May; 107(5):569-75. PubMed ID: 26918382 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. Placencio-Hickok VR; Lauzon M; Moshayedi N; Guan M; Kim S; Nissen N; Lo S; Pandol S; Larson BK; Gong J; Hendifar AE; Osipov A Pancreatology; 2022 Jan; 22(1):92-97. PubMed ID: 34657790 [TBL] [Abstract][Full Text] [Related]
7. Stromal hyaluronan accumulation is associated with low tumor grade and nodal metastases in pancreatic ductal adenocarcinoma. Larson BK; Guan M; Placencio V; Tuli R; Hendifar AE Hum Pathol; 2019 Aug; 90():37-44. PubMed ID: 31121193 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153 [TBL] [Abstract][Full Text] [Related]
11. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma. Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302 [TBL] [Abstract][Full Text] [Related]
12. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Fermér C; Nilsson O; Seppänen H; Haglund C PLoS One; 2015; 10(6):e0129012. PubMed ID: 26053486 [TBL] [Abstract][Full Text] [Related]
13. Increased Expression of HYAL1 in Pancreatic Ductal Adenocarcinoma. Kohi S; Sato N; Cheng XB; Koga A; Hirata K Pancreas; 2016 Nov; 45(10):1467-1473. PubMed ID: 27622341 [TBL] [Abstract][Full Text] [Related]
14. KLF9 Is a Prognostic Indicator in Human Pancreatic Ductal Adenocarcinoma. Mao Z; Fan X; Zhang J; Wang X; Ma X; Michalski CW; Zhang Y Anticancer Res; 2017 Jul; 37(7):3795-3799. PubMed ID: 28668877 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of transmembrane protein 2 (TMEM2), a novel hyaluronidase, predicts poor prognosis in pancreatic ductal adenocarcinoma. Kudo Y; Sato N; Adachi Y; Amaike T; Koga A; Kohi S; Noguchi H; Nakayama T; Hirata K Pancreatology; 2020 Oct; 20(7):1479-1485. PubMed ID: 32948431 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of YKL-40 Predicts Poor Prognosis in Patients Undergoing Curative Resection of Pancreatic Cancer. Chen HT; Zheng JM; Zhang YZ; Yang M; Wang YL; Man XH; Chen Y; Cai QC; Li ZS Pancreas; 2017 Mar; 46(3):323-334. PubMed ID: 28099248 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630 [TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8 Yamaki S; Yanagimoto H; Tsuta K; Ryota H; Kon M Int J Clin Oncol; 2017 Aug; 22(4):726-733. PubMed ID: 28314962 [TBL] [Abstract][Full Text] [Related]
19. High-molecular-weight hyaluronan produced by activated pancreatic stellate cells promotes pancreatic cancer cell migration via paracrine signaling. Junliang L; Lili W; Xiaolong L; Xuguang L; Huanwen W; Zhiyong L Biochem Biophys Res Commun; 2019 Jul; 515(3):493-498. PubMed ID: 31171359 [TBL] [Abstract][Full Text] [Related]
20. A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells. Kohi S; Sato N; Cheng XB; Koga A; Higure A; Hirata K Clin Exp Metastasis; 2016 Mar; 33(3):225-30. PubMed ID: 26589701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]